Ondine Biomedical (LSE:OBI) Inventories, Raw Materials & Components: £0.44 Mil (As of Dec. 2025)


LSE:OBI Ondine Biomedical Inc LSE:OBI
28 GF Score
Price £0.15
GF Value £0.10
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Ondine Biomedical Inventories, Raw Materials & Components?

Ondine Biomedical LSE:OBI -1.69% 28 Inventories, Raw Materials & Components is £0.44 Mil as of Dec. 2025. GuruFocus rates LSE:OBI with a GF Score™ of 28/100 and a GF Value™ of £0.10 (Significantly Overvalued). The stock has 9 warning signs investors should review.

Ondine Biomedical's inventories, raw materials & components for the quarter that ended in Dec. 2025 was £0.44 Mil.

Ondine Biomedical's quarterly raw materials increased from Dec. 2024 (£0.28 Mil) to Jun. 2025 (£0.29 Mil) and increased from Jun. 2025 (£0.29 Mil) to Dec. 2025 (£0.44 Mil).

Ondine Biomedical's annual raw materials declined from Dec. 2023 (£0.33 Mil) to Dec. 2024 (£0.28 Mil) but then increased from Dec. 2024 (£0.28 Mil) to Dec. 2025 (£0.44 Mil).

Ondine Biomedical Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Ondine Biomedical's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ondine Biomedical Inventories, Raw Materials & Components Chart

Ondine Biomedical Annual Data
Trend Dec10 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.33 0.57 0.33 0.28 0.44

Ondine Biomedical Semi-Annual Data
Jun09 Dec09 Jun10 Dec10 Jun11 Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.33 0.22 0.28 0.29 0.44
LSE:OBI
28GF Score
Ondine Biomedical Inc LSE:OBI
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ondine Biomedical Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of £0.44 Mil mean?
Ondine Biomedical (LSE:OBI) has a Inventories, Raw Materials & Components of £0.44 Mil as of Dec. 2025. Raw materials are the components a company uses for its main products. View historical data on Ondine Biomedical and its competitors.
Is Ondine Biomedical's Inventories, Raw Materials & Components too high?
Ondine Biomedical's current Inventories, Raw Materials & Components is £0.44 Mil. Overall, Ondine Biomedical has a GF Score™ of 28/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ondine Biomedical's Inventories, Raw Materials & Components compare to VRTX and REGN?
Ondine Biomedical's Inventories, Raw Materials & Components of £0.44 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Biotechnology company?
A good Inventories, Raw Materials & Components depends on the Biotechnology industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Ondine Biomedical and its competitors. Ondine Biomedical's current Inventories, Raw Materials & Components is £0.44 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ondine Biomedical stock overvalued right now?
Based on GuruFocus' analysis, Ondine Biomedical (LSE:OBI) is currently considered Significantly Overvalued. The stock's GF Value™ is £0.10, compared to a current price of £0.15 — trading 45% above its estimated fair value. The current Inventories, Raw Materials & Components is £0.44 Mil. Ondine Biomedical's overall GF Score™ is 28/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Ondine Biomedical (LSE:OBI), the current Inventories, Raw Materials & Components is £0.44 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ondine Biomedical (LSE:OBI) Overvalued in 2026?

Based on GuruFocus' analysis, Ondine Biomedical stock appears to be overvalued. The current stock price of £0.15 is trading 45% above its estimated GF Value™ of £0.10. GuruFocus considers Ondine Biomedical to be Significantly Overvalued.

Key valuation signals for LSE:OBI:

  • Inventories, Raw Materials & Components: £0.44 Mil
  • GF Value™: £0.10 vs. price of £0.15 (45% above fair value)
  • GF Score™: 28/100 with 9 warning signs

No single metric tells the full story. See the LSE:OBI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ondine Biomedical Business Description

Other Exchanges OBIMF:USAVF5:Germany
Address 1100 Melville Street, Suite 888, Vancouver, BC, CAN, V6E4A6
Ondine Biomedical Inc is a life sciences company, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. The company has created a platform technology called antimicrobial photodynamic disinfection, or photodisinfection, to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings. Canada is the major revenue generator for the group. The company has one reportable operating segment that is antimicrobial photodynamic therapy (aPDT) products.
28GF Score

Get the complete analysis for LSE:OBI

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.15
Price
£0.10
GF Value